Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids

Po Hsun Huang, Chih Pei Lin, Chao Hung Wang, Chia Hung Chiang, Hsiao Ya Tsai, Jia Shiong Chen, Feng Yen Lin, Hsin Bang Leu, Tao Cheng Wu, Jaw Wen Chen, Shing Jong Lin

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Niacin was shown to inhibit acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Here, we investigated whether niacin can increase blood flow recovery after tissue ischemia by enhancing endothelial progenitor cell (EPC) functions in diabetic mice. Starting at 4 weeks after the onset of diabetes, vehicle or niacin (40 mg/kg/day) was administered daily by gavage to streptozotocin (STZ)-induced diabetic mice and diabetic endothelial nitric oxide synthase (eNOS)-deficient mice. Unilateral hindlimb ischemia surgery was conducted after 2 weeks of vehicle or niacin treatment. Compared to the control group, the niacin group had significantly increased ischemic/non-ischemic limb blood perfusion ratio and higher capillary density. These effects were markedly reduced in STZ-induced diabetic eNOS-deficient mice. Flow cytometry analysis showed impaired EPC-like cell (Sca-1+/Flk-1+) mobilization after ischemia surgery in diabetic mice but augmented mobilization in the mice treated with niacin. Diabetes was induced by administering STZ to FVB mice that received eGFP mouse bone marrow cells to evaluate effects of niacin on bone marrow-derived EPC homing and differentiation to endothelial cells. Differentiation of bone marrow-derived EPCs to endothelial cells in the ischemic tissue around vessels in diabetic mice that received niacin treatment, was significantly increased than that in control group. By in vitro studies, incubation with niacin in high-glucose medium reduced H2O2 production, cell apoptosis, and improved high glucose-suppressed EPC functions by nitric oxide-related mechanisms. Our findings demonstrate that niacin increases blood flow recovery after tissue ischemia in diabetic mice through enhancing EPC mobilization and functions via nitric oxide-related pathways.

Original languageEnglish
Pages (from-to)377-389
Number of pages13
JournalAngiogenesis
Volume15
Issue number3
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Niacin
Endothelial cells
Ischemia
Lipids
Plasmas
Streptozocin
Bone
Blood
Nitric Oxide Synthase Type III
Tissue
Medical problems
Surgery
Nitric Oxide
Endothelial Cells
Bone Marrow
Endothelial Progenitor Cells
Glucose
Recovery
Control Groups
Flow cytometry

Keywords

  • Diabetes
  • Endothelial progenitor cells
  • Ischemia
  • Niacin
  • Nitric oxide

ASJC Scopus subject areas

  • Cancer Research
  • Physiology
  • Clinical Biochemistry

Cite this

Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids. / Huang, Po Hsun; Lin, Chih Pei; Wang, Chao Hung; Chiang, Chia Hung; Tsai, Hsiao Ya; Chen, Jia Shiong; Lin, Feng Yen; Leu, Hsin Bang; Wu, Tao Cheng; Chen, Jaw Wen; Lin, Shing Jong.

In: Angiogenesis, Vol. 15, No. 3, 09.2012, p. 377-389.

Research output: Contribution to journalArticle

Huang, Po Hsun ; Lin, Chih Pei ; Wang, Chao Hung ; Chiang, Chia Hung ; Tsai, Hsiao Ya ; Chen, Jia Shiong ; Lin, Feng Yen ; Leu, Hsin Bang ; Wu, Tao Cheng ; Chen, Jaw Wen ; Lin, Shing Jong. / Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids. In: Angiogenesis. 2012 ; Vol. 15, No. 3. pp. 377-389.
@article{d55f2a1bc259473587c04e971df0c1d6,
title = "Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids",
abstract = "Niacin was shown to inhibit acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Here, we investigated whether niacin can increase blood flow recovery after tissue ischemia by enhancing endothelial progenitor cell (EPC) functions in diabetic mice. Starting at 4 weeks after the onset of diabetes, vehicle or niacin (40 mg/kg/day) was administered daily by gavage to streptozotocin (STZ)-induced diabetic mice and diabetic endothelial nitric oxide synthase (eNOS)-deficient mice. Unilateral hindlimb ischemia surgery was conducted after 2 weeks of vehicle or niacin treatment. Compared to the control group, the niacin group had significantly increased ischemic/non-ischemic limb blood perfusion ratio and higher capillary density. These effects were markedly reduced in STZ-induced diabetic eNOS-deficient mice. Flow cytometry analysis showed impaired EPC-like cell (Sca-1+/Flk-1+) mobilization after ischemia surgery in diabetic mice but augmented mobilization in the mice treated with niacin. Diabetes was induced by administering STZ to FVB mice that received eGFP mouse bone marrow cells to evaluate effects of niacin on bone marrow-derived EPC homing and differentiation to endothelial cells. Differentiation of bone marrow-derived EPCs to endothelial cells in the ischemic tissue around vessels in diabetic mice that received niacin treatment, was significantly increased than that in control group. By in vitro studies, incubation with niacin in high-glucose medium reduced H2O2 production, cell apoptosis, and improved high glucose-suppressed EPC functions by nitric oxide-related mechanisms. Our findings demonstrate that niacin increases blood flow recovery after tissue ischemia in diabetic mice through enhancing EPC mobilization and functions via nitric oxide-related pathways.",
keywords = "Diabetes, Endothelial progenitor cells, Ischemia, Niacin, Nitric oxide",
author = "Huang, {Po Hsun} and Lin, {Chih Pei} and Wang, {Chao Hung} and Chiang, {Chia Hung} and Tsai, {Hsiao Ya} and Chen, {Jia Shiong} and Lin, {Feng Yen} and Leu, {Hsin Bang} and Wu, {Tao Cheng} and Chen, {Jaw Wen} and Lin, {Shing Jong}",
year = "2012",
month = "9",
doi = "10.1007/s10456-012-9267-z",
language = "English",
volume = "15",
pages = "377--389",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids

AU - Huang, Po Hsun

AU - Lin, Chih Pei

AU - Wang, Chao Hung

AU - Chiang, Chia Hung

AU - Tsai, Hsiao Ya

AU - Chen, Jia Shiong

AU - Lin, Feng Yen

AU - Leu, Hsin Bang

AU - Wu, Tao Cheng

AU - Chen, Jaw Wen

AU - Lin, Shing Jong

PY - 2012/9

Y1 - 2012/9

N2 - Niacin was shown to inhibit acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Here, we investigated whether niacin can increase blood flow recovery after tissue ischemia by enhancing endothelial progenitor cell (EPC) functions in diabetic mice. Starting at 4 weeks after the onset of diabetes, vehicle or niacin (40 mg/kg/day) was administered daily by gavage to streptozotocin (STZ)-induced diabetic mice and diabetic endothelial nitric oxide synthase (eNOS)-deficient mice. Unilateral hindlimb ischemia surgery was conducted after 2 weeks of vehicle or niacin treatment. Compared to the control group, the niacin group had significantly increased ischemic/non-ischemic limb blood perfusion ratio and higher capillary density. These effects were markedly reduced in STZ-induced diabetic eNOS-deficient mice. Flow cytometry analysis showed impaired EPC-like cell (Sca-1+/Flk-1+) mobilization after ischemia surgery in diabetic mice but augmented mobilization in the mice treated with niacin. Diabetes was induced by administering STZ to FVB mice that received eGFP mouse bone marrow cells to evaluate effects of niacin on bone marrow-derived EPC homing and differentiation to endothelial cells. Differentiation of bone marrow-derived EPCs to endothelial cells in the ischemic tissue around vessels in diabetic mice that received niacin treatment, was significantly increased than that in control group. By in vitro studies, incubation with niacin in high-glucose medium reduced H2O2 production, cell apoptosis, and improved high glucose-suppressed EPC functions by nitric oxide-related mechanisms. Our findings demonstrate that niacin increases blood flow recovery after tissue ischemia in diabetic mice through enhancing EPC mobilization and functions via nitric oxide-related pathways.

AB - Niacin was shown to inhibit acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Here, we investigated whether niacin can increase blood flow recovery after tissue ischemia by enhancing endothelial progenitor cell (EPC) functions in diabetic mice. Starting at 4 weeks after the onset of diabetes, vehicle or niacin (40 mg/kg/day) was administered daily by gavage to streptozotocin (STZ)-induced diabetic mice and diabetic endothelial nitric oxide synthase (eNOS)-deficient mice. Unilateral hindlimb ischemia surgery was conducted after 2 weeks of vehicle or niacin treatment. Compared to the control group, the niacin group had significantly increased ischemic/non-ischemic limb blood perfusion ratio and higher capillary density. These effects were markedly reduced in STZ-induced diabetic eNOS-deficient mice. Flow cytometry analysis showed impaired EPC-like cell (Sca-1+/Flk-1+) mobilization after ischemia surgery in diabetic mice but augmented mobilization in the mice treated with niacin. Diabetes was induced by administering STZ to FVB mice that received eGFP mouse bone marrow cells to evaluate effects of niacin on bone marrow-derived EPC homing and differentiation to endothelial cells. Differentiation of bone marrow-derived EPCs to endothelial cells in the ischemic tissue around vessels in diabetic mice that received niacin treatment, was significantly increased than that in control group. By in vitro studies, incubation with niacin in high-glucose medium reduced H2O2 production, cell apoptosis, and improved high glucose-suppressed EPC functions by nitric oxide-related mechanisms. Our findings demonstrate that niacin increases blood flow recovery after tissue ischemia in diabetic mice through enhancing EPC mobilization and functions via nitric oxide-related pathways.

KW - Diabetes

KW - Endothelial progenitor cells

KW - Ischemia

KW - Niacin

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=84865146535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865146535&partnerID=8YFLogxK

U2 - 10.1007/s10456-012-9267-z

DO - 10.1007/s10456-012-9267-z

M3 - Article

C2 - 22467057

AN - SCOPUS:84865146535

VL - 15

SP - 377

EP - 389

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 3

ER -